{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:57:06Z","timestamp":1776707826796,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.urolonc.2015.10.009","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T13:31:05Z","timestamp":1447507865000},"page":"120.e9-120.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Sally M.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone M.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Clouston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lupat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6154-4947","authenticated-orcid":false,"given":"Nishanth","family":"Krishnananthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Risbridger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renea","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian G.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2015.10.009_bib1","doi-asserted-by":"crossref","unstructured":"Siegel R, et al. 2014 American Cancer Society, Inc. CA Cancer J Clin 2014;64:9\u201329","DOI":"10.3322\/caac.21208"},{"key":"10.1016\/j.urolonc.2015.10.009_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2015.10.009_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2015.10.009_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/aja.2011.150","article-title":"The role of BRCA1 and BRCA2 in prostate cancer","volume":"14","author":"Castro","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.urolonc.2015.10.009_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/annonc\/mdv004","article-title":"Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes","volume":"26","author":"Kote-Jarai","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2015.10.009_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","article-title":"A recurrent mutation in PALB2 in Finnish cancer families","volume":"446","author":"Erkko","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2015.10.009_bib7","doi-asserted-by":"crossref","first-page":"294575","DOI":"10.1155\/2014\/294575","article-title":"CHEK2 (*) 1100delC mutation and risk of prostate cancer","volume":"2014","author":"Hale","year":"2014","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.urolonc.2015.10.009_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.bjc.6604847","article-title":"A recurrent truncating germline mutation in the BRIP1\/FANCJ gene and susceptibility to prostate cancer","volume":"100","author":"Kote-Jarai","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2015.10.009_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10689-010-9388-8","article-title":"Hereditary prostate cancer as a feature of Lynch syndrome","volume":"10","author":"Bauer","year":"2011","journal-title":"Fam Cancer"},{"key":"10.1016\/j.urolonc.2015.10.009_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.2012.44.1238","article-title":"Elevated risk of prostate cancer among men with Lynch syndrome","volume":"31","author":"Raymond","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.10.009_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1469-1809.2003.00022.x","article-title":"Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence","volume":"67","author":"Valer","year":"2003","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.urolonc.2015.10.009_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0090-4295(00)00891-8","article-title":"Autosomal dominant inheritance of prostate cancer: a confirmatory study","volume":"57","author":"Verhage","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.10.009_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1086\/301862","article-title":"Evidence for autosomal dominant inheritance of prostate cancer","volume":"62","author":"Schaid","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2015.10.009_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/oxfordjournals.aje.a009313","article-title":"Segregation analysis of prostate cancer in Sweden: support for dominant inheritance","volume":"146","author":"Gronberg","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2015.10.009_bib15","first-page":"471","article-title":"Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada","volume":"13","author":"Gong","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2015.10.009_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/gepi.20433","article-title":"Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies","volume":"34","author":"MacInnis","year":"2010","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.urolonc.2015.10.009_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrurol.2013.266","article-title":"The genetic epidemiology of prostate cancer and its clinical implications","volume":"11","author":"Eeles","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2015.10.009_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng.2560","article-title":"Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array","volume":"45","author":"Eeles","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2015.10.009_bib19","doi-asserted-by":"crossref","unstructured":"Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, et al. Risk analysis of prostate cancer in PRACTICAL, a multinational consortium, using 25 known prostate cancer susceptibility lociCancer Epidemiol Biomarkers Prev 2015;24:1121-1129 [1538-7755, Electronic].","DOI":"10.1158\/1055-9965.EPI-15-1005"},{"key":"10.1016\/j.urolonc.2015.10.009_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.urolonc.2015.10.009_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"1000 Genomes Project Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2015.10.009_bib22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/pros.22849","article-title":"Mutational landscape of candidate genes in familial prostate cancer","volume":"74","author":"Johnson","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2015.10.009_bib23","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1158\/0008-5472.CAN-04-1651","article-title":"CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer","volume":"64","author":"Zeigler-Johnson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2015.10.009_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.27665","article-title":"Germline variants of base excision repair genes and breast cancer: a polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk","volume":"132","author":"Popanda","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2015.10.009_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1476-4598-13-245","article-title":"MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer","volume":"13","author":"Liu","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.urolonc.2015.10.009_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ijrobp.2010.06.023","article-title":"A gene expression signature for chemoradiosensitivity of colorectal cancer cells","volume":"78","author":"Spitzner","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2015.10.009_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng.527","article-title":"Identification of DOK genes as lung tumor suppressors","volume":"42","author":"Berger","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2015.10.009_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.molcel.2014.03.021","article-title":"Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability","volume":"54","author":"Savage","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.urolonc.2015.10.009_bib29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PPO.0b013e31823e5387","article-title":"The genetics of cancer risk","volume":"17","author":"Pomerantz","year":"2011","journal-title":"Cancer J"},{"key":"10.1016\/j.urolonc.2015.10.009_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.eururo.2014.08.007","article-title":"Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis","volume":"67","author":"Risbridger","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.10.009_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/B:JOMG.0000048770.90334.3b","article-title":"The genetic epidemiology of breast cancer genes","volume":"9","author":"Thompson","year":"2004","journal-title":"J Mammary Gland Biol Neoplasia"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915004950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915004950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:06:35Z","timestamp":1761041195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915004950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1078143915004950"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.10.009","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}